| CMM | cell-mediated mutagenesis; cutaneous malignant melanoma |
|---|---|
| EMP | electric membrane property; electromagnetic pulse; Embden-Meyerhof pathway; external membrane potent... |
| FMN | first malignant neoplasm; flavin mononucleotide; frontomaxillonasal [suture] |
| HCMM | hereditary cutaneous malignant melanoma |
| MA | malignant arrhythmia; management and administration; mandelic acid; masseter; Master of Arts; matern... |
| malignant tertian malarial parasite | A species of protozoa that is the causal agent of falciparum malaria (malaria, falciparum). It is most prevalent in the tropics and subtropics. (12 Dec 1998) |
|---|---|
| malignant tumour | A mass of cancer cells. These cells have uncontrolled growth and will invade surrounding tissues and spread to distant sites of the body, setting up new cancer sites, a process called metastasis. (09 Oct 1997) |
| Rhodesian malignant theileriosis | A highly pathogenic protozoan disease of cattle in Zimbabwe caused by Theileria parva bovis and transmitted by the tick Rhipicephalus appendiculatus. See: kaodzera. Tropical theileriosis, a highly pathogenic protozoan disease of cattle in northern Africa, southern Europe, the Near and Middle East, and central Asia; caused by Theileria annulata and transmitted by ticks of the genus Hyalomma. Synonym: Mediterranean theileriosis. (05 Mar 2000) |
| midline malignant reticulosis granuloma | Destruction of the nasal septum, hard palate, lateral nasal walls, paranasal sinuses, skin of the face, orbit and nasopharynx by an inflammatory infiltrate with atypical lymphocytic and histiocytic cells; presumably a form of lymphoma in most cases. An obsolete term for polymorphic reticulosis. Synonym: granuloma gangrenescens, malignant granuloma, midline malignant reticulosis granuloma. (05 Mar 2000) |
| mixed tumour, malignant | A malignant tumour composed of more than one type of neoplastic tissue. (12 Dec 1998) |
| pleural effusion, malignant | Presence of fluid in the pleural cavity as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells. (12 Dec 1998) |
| histiocytic disorders, malignant | Distinctive neoplastic disorders of histiocytes. Included are acute monocytic leukaemias, malignant histiocytosis (histiocytosis, malignant), and true histiocytic lymphomas. (12 Dec 1998) |
| histiocytosis, malignant | A rare, usually rapidly progressive disorder, characterised by abrupt onset, fever, weight loss, hepato-splenomegaly, pancytopenia, and lymphadenopathy. (12 Dec 1998) |
| hypertension, malignant | Severe hypertension characterised by papilledema and necrosis of small arteries and arterioles. The diastolic pressure is generally greater than 130 mm hg. (12 Dec 1998) |
| neuroleptic malignant syndrome | <syndrome> This describes the combination of catatonic rigidity, stupor, unstable blood pressure, fever, profuse sweating, sweating and incontinence as a reaction to antipsychotic agents (phenothiazines) in therapeutic doses. Origin: Gr. Lepsis = a taking hold (27 Sep 1997) |
| desmoplastic malignant melanoma | <tumour> A melanoma with marked fibrosis surrounding atypical spindle-shaped melanocytes in the dermis. (05 Mar 2000) |
| low malignant potential tumour | A neoplasm of the ovary, usually arising in young women, composed of complex epithelial hyperplasia without stromas invasion; may recur if incompletely removed surgically, but is clinically less aggressive than carcinoma. Synonym: low malignant potential tumour. (05 Mar 2000) |
| bladder neoplasms | Cancers or tumours of the bladder. The majority of bladder neoplasms are of the transitional cell variety and are usually papillary and multicentric. (12 Dec 1998) |
| bone marrow neoplasms | Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as myeloma. most bone marrow neoplasms are metastatic. (12 Dec 1998) |
| breast neoplasms, male | Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females. Two-thirds of patients present with intraductal carcinoma. The average age of onset is 60 years for men. Orchiectomy was the standard treatment but it has been replaced by tamoxifen as the initial therapy since oestrogen-receptor-positive tumours are predominant in males. Orchiectomy and mastectomy may be used if initial drug therapy is not successful. The prognosis is worse than that for females. (12 Dec 1998) |